Periplaneta americana extract CII-3 triggers cell senescence through activating ROS-p38 MAPK-p53 signaling pathway in SKOV3 cells

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Applied Bio Materials Pub Date : 2024-09-13 DOI:10.1016/j.tice.2024.102561
Lu Tian , Heng Liu , Yue Zhou , Chenggui Zhang , Ziying Bi , Ting Wu
{"title":"Periplaneta americana extract CII-3 triggers cell senescence through activating ROS-p38 MAPK-p53 signaling pathway in SKOV3 cells","authors":"Lu Tian ,&nbsp;Heng Liu ,&nbsp;Yue Zhou ,&nbsp;Chenggui Zhang ,&nbsp;Ziying Bi ,&nbsp;Ting Wu","doi":"10.1016/j.tice.2024.102561","DOIUrl":null,"url":null,"abstract":"<div><p>This study aimed to investigate effect of Periplaneta americana extract CII-3 (CII-3) in senescence of SKOV3 cells. Proliferation, colony forming and cell senescence of SKOV3 cells were determined. ROS production was evaluated by flow cytometry. Transcription of telomerase (TERT), p38 MAPK and p53 gene and protein expression of p-p38 MAPK and p-p53, were identified. CII-3 at different concentrations significantly inhibited SKOV3 proliferation, and 80 μg/ml demonstrated the highest inhibitory effect. CII-3 significantly blocked cell cycle in G0/G1 phase (<em>P</em>&lt;0.01) and reduced colony forming efficiency (<em>P</em>&lt;0.001) of SKOV3 cells compared to those in Control group. CII-3 significantly increased SA-β-Gal positive staining SKOV3 cells (<em>P</em>&lt;0.001) and reduced mitochondrial membrane potential (<em>P</em>&lt;0.01) compared to those in Control group. CII-3 markedly decreased TERT gene transcription of SKOV3 cells compared to that in Control group (<em>P</em>&lt;0.001). CII-3 also triggered significantly higher ROS levels in SKOV3 cells compared to that in Control group (<em>P</em>&lt;0.001). CII-3 significantly increased p-p38 MAPK (<em>P</em>&lt;0.001), p-p53 (<em>P</em>&lt;0.001) and p21 (<em>P</em>&lt;0.001) expressions of SKOV3 cells compared to those in Control group. In conclusion, CII-3 triggered cell senescence of SKOV3 cells through activating ROS-p38 MAPK-p53 signaling pathway. This study would provide a promising strategy for inhibiting cancer cell proliferation by including cell senescence.</p></div>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-09-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0040816624002623","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

This study aimed to investigate effect of Periplaneta americana extract CII-3 (CII-3) in senescence of SKOV3 cells. Proliferation, colony forming and cell senescence of SKOV3 cells were determined. ROS production was evaluated by flow cytometry. Transcription of telomerase (TERT), p38 MAPK and p53 gene and protein expression of p-p38 MAPK and p-p53, were identified. CII-3 at different concentrations significantly inhibited SKOV3 proliferation, and 80 μg/ml demonstrated the highest inhibitory effect. CII-3 significantly blocked cell cycle in G0/G1 phase (P<0.01) and reduced colony forming efficiency (P<0.001) of SKOV3 cells compared to those in Control group. CII-3 significantly increased SA-β-Gal positive staining SKOV3 cells (P<0.001) and reduced mitochondrial membrane potential (P<0.01) compared to those in Control group. CII-3 markedly decreased TERT gene transcription of SKOV3 cells compared to that in Control group (P<0.001). CII-3 also triggered significantly higher ROS levels in SKOV3 cells compared to that in Control group (P<0.001). CII-3 significantly increased p-p38 MAPK (P<0.001), p-p53 (P<0.001) and p21 (P<0.001) expressions of SKOV3 cells compared to those in Control group. In conclusion, CII-3 triggered cell senescence of SKOV3 cells through activating ROS-p38 MAPK-p53 signaling pathway. This study would provide a promising strategy for inhibiting cancer cell proliferation by including cell senescence.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Periplaneta americana 提取物 CII-3 通过激活 SKOV3 细胞中的 ROS-p38 MAPK-p53 信号通路引发细胞衰老
本研究旨在探讨美洲长春花提取物CII-3(CII-3)对SKOV3细胞衰老的影响。研究测定了 SKOV3 细胞的增殖、集落形成和细胞衰老。流式细胞术评估了 ROS 的产生。鉴定了端粒酶(TERT)、p38 MAPK 和 p53 基因的转录以及 p-p38 MAPK 和 p-p53 的蛋白表达。不同浓度的 CII-3 均能明显抑制 SKOV3 的增殖,其中 80 μg/ml 的抑制作用最强。与对照组相比,CII-3能明显阻滞SKOV3细胞G0/G1期的细胞周期(P<0.01),降低集落形成效率(P<0.001)。与对照组相比,CII-3 能明显增加 SKOV3 细胞 SA-β-Gal 阳性染色(P<0.001)并降低线粒体膜电位(P<0.01)。与对照组相比,CII-3 显著降低了 SKOV3 细胞的 TERT 基因转录(P<0.001)。与对照组相比,CII-3 在 SKOV3 细胞中引发的 ROS 水平也明显升高(P<0.001)。与对照组相比,CII-3 能明显增加 SKOV3 细胞中 p-p38 MAPK(P<0.001)、p-p53(P<0.001)和 p21(P<0.001)的表达。总之,CII-3通过激活ROS-p38 MAPK-p53信号通路引发SKOV3细胞衰老。这项研究将为通过细胞衰老抑制癌细胞增殖提供一种有前景的策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
期刊最新文献
A Systematic Review of Sleep Disturbance in Idiopathic Intracranial Hypertension. Advancing Patient Education in Idiopathic Intracranial Hypertension: The Promise of Large Language Models. Anti-Myelin-Associated Glycoprotein Neuropathy: Recent Developments. Approach to Managing the Initial Presentation of Multiple Sclerosis: A Worldwide Practice Survey. Association Between LACE+ Index Risk Category and 90-Day Mortality After Stroke.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1